No Data
No Data
Flora Announces Appointment of Patrick Moloney as Head of Product Development for Vessel
UBS Adjusts Price Target on Flora Growth to $12 From $11.50, Maintains Neutral Rating
FDA Solicits Public Comments On Use Of Cannabis-derived Products In Veterinary Medicine
Little Excitement Around Flora Growth Corp.'s (NASDAQ:FLGC) Revenues As Shares Take 27% Pounding
Clifford Starke's Holdings in Flora Growth Corp.
Express News | Flora Growth Corp: Files for Offering of 2.9 Mln of Common Shares - SEC Filing